SmallCaps
ASX:ECSPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals

ECS Botanics Holdings Ltd

$0.005
Day Range
$0.004 – $0.005
52 Week Range
$0.004 – $0.010
Volume
1.35M
Avg Volume (10D)
671.21K
Market Cap
$7.18M

Price Chart

OHLC · volume · moving averages

$0.005-$0.002 (-25.00%)over 6M
Hi$0.008Lo$0.004
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today's trading range

Open
$0.005
Previous Close
$0.005
Day High
$0.005
Day Low
$0.004
52 Week High
$0.010
52 Week Low
$0.004

Valuation

Fundamental multiples

Market Cap
7.18M
Shares Outstanding
1.60B
Price to Book
0.27

Trading Activity

Volume & order book

Volume
1.35M
Value Traded
5.70K
Bid
$0.004 × 9,349,502
Ask
$0.005 × 5,423,602

Performance

Returns across timeframes

1 Day
-11.11%
5 Day
-20.00%
13 Week
-20.00%
52 Week
-55.56%
YTD
-38.46%

Technical Indicators

Momentum & moving averages

RSI (14)
44.38
50-Day SMA
$0.005
200-Day SMA
$0.006

— From the desk

Latest News

ECS Botanics Achieves Positive Cash Flow Breakthrough in September Quarter
Biotechnology

ECS Botanics Achieves Positive Cash Flow Breakthrough in September Quarter

ECS Botanics Holdings (ASX: ECS) has delivered a positive net operating cash flow of $140,000 for the three months to end September, representing an improvement of $1.6 million on the June quarter and $900,000 on the same time last year. The company’s direct-to-consumer (B2C) strategy generated strong results to complement its established business-to-business (B2B) and export […]

ECS Botanics reports 50% increase in cannabis yields with new crop enclosure designs
Biotechnology

ECS Botanics reports 50% increase in cannabis yields with new crop enclosure designs

Australian medicinal cannabis cultivator and manufacturer ECS Botanics (ASX: ECS) has reported a 50% increase in cannabis flower yields following the first harvest from its redesigned protective crop enclosures. The harvest produced 656 kilograms (wet weight) of flower compared to the previous high of 437kg of the same strain, also recording improvements in flower quality […]

ECS Botanics signs medicinal cannabis supply deal with MediCann Health
Biotechnology

ECS Botanics signs medicinal cannabis supply deal with MediCann Health

Victorian medicinal cannabis cultivator and manufacturer ECS Botanics (ASX: ECS) has secured a deal to supply $24 million of pharmaceutical-grade medicinal cannabis dried flower to Perth-based MediCann Health. The agreement will commence in January 2024 with over four tonnes of product to be delivered exclusively to MediCann over five years. It stipulates annual volumes of […]

Ongoing cannabis product demand drives more revenue growth for ECS Botanics
Biotechnology

Ongoing cannabis product demand drives more revenue growth for ECS Botanics

Medicinal cannabis and hemp company ECS Botanics (ASX: ECS) has announced it is on track to deliver another consecutive quarter of revenue growth thanks to sales of its dried flower and cannabis oil products. The company expects to report revenue of about $2 million for the quarter due to end 31 March, which would represent […]